Cytotoxicity of methylsulfonylmethane on gastrointestinal (AGS, HepG2, and KEYSE-30) cancer cell lines

Journal of Gastrointestinal Cancer

Volumn 43, Issue 3, 2012, Pages 420-425

  Jafari, Naser ^a   Bohlooli, Shahab ^a   Mohammadi, Sadollah ^a   Mazani, Mohammad ^a  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Cancer cell lines; Cytotoxicity; Methylsulfonylmethane; MSM

Indexed keywords

ACRIDINE ORANGE; DIMETHYL SULFONE; ETHIDIUM BROMIDE; NEUTRAL RED;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CONTROLLED STUDY; CYTOTOXICITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; LIVER CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; STOMACH CARCINOMA;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; DIMETHYL SULFOXIDE; ESOPHAGEAL NEOPLASMS; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; STOMACH NEOPLASMS; SULFONES; TUMOR CELLS, CULTURED;

EID: 84866392963     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-011-9291-z     Document Type: Article

References (23)

1. Methylsulfonylmethane (MSM). Monograph. Altern. Med. Rev. 2003. 8(4):438-41.
2. Christy M. MSM-the super-supplement of the decade. Arizona: Wishland Inc; 1997.
3. Jacob S, Appleton J. MSM the definitive guide: the nutritional breakthrough for arthritis, allergies and more. Los Angeles: Freedom Press; 2002.
4. Beilke MA, Collins-Lech C, Sohnle PG. Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med. 1987;110(1):91-6.
5. McCabe D et al. Polar solvents in the chemoprevention of dimethylbenzanthracene-induced rat mammary cancer. Arch Surg. 1986;121(12):1455-9.
6. Caron JM et al. Methyl sulfone induces loss of metastatic properties and reemergence of normal phenotypes in a metastatic cloudman S-91 (M3) murine melanoma cell line. PLoS One. 2010;5(8):e11788.
7. Cox WI, Specter S, Friedman H. Susceptibility of Friend erythroleukemia cells to natural cytotoxicity after in vitro treatment with dimethyl sulfoxide. Proc Soc Exp Biol Med. 1982;169(3):337-42.
8. Ebisuzaki K. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res. 2003;23(1A):453-8.
9. Satia JA et al. Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle Study. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1419-28.
10. Alam SS, Layman DL. Dimethyl sulfoxide as a cholesterollowering agent in cultured fibroblasts exposed to low density lipoproteins. Biochim Biophys Acta. 1982;710(3):306-13.
11. Layman DL. Growth inhibitory effects of dimethyl sulfoxide and dimethyl sulfone on vascular smooth muscle and endothelial cells in vitro. In Vitro Cell Dev Biol. 1987;23(6):422-8.
12. Morton JI, Siegel BV. Effects of oral dimethyl sulfoxide and dimethyl sulfone on murine autoimmune lymphoproliferative disease. Proc Soc Exp Biol Med. 1986;183(2):227-30.
13. Barrager E et al. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. J Altern Complement Med. 2002;8(2):167-73.
14. Magnuson BA et al. Oral developmental toxicity study of methylsulfonylmethane in rats. Food Chem Toxicol. 2007;45(6):977-84.
15. Horvath K et al. Toxicity of methylsulfonylmethane in rats. Food Chem Toxicol. 2002;40(10):1459-62.
16. Kelsen D et al. Principles and practice of gastrointestinal oncology. 2008. New York: Lippincott, Williams & Wilkins.
17. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354-62.
18. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003;14 Suppl 2:ii31-6.
19. Cabibbo G, Craxi A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2010;14(4):352-5.
20. Cervantes A et al. The treatment of advanced gastric cancer: current strategies and future perspectives. Ann Oncol. 2008;19 Suppl 5:v103-7.
21. Ribble D et al. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005;5:12.
22. Levesque AA et al. Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints. Oncogene. 2005;24(23):3786-96.
23. Honda I, Watanabe S, Fujita Y. Preoperative adjuvant chemotherapy with oral anticancer agents for stomach cancer. Gan To Kagaku Ryoho. 1997;24(9):1109-17.